Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649

Concordance between IHC and endpoint RT-PCR based on ER, PR, and HER2 status
Variables Concordance
OPA PPA NPA κ value P-value
ER 68.3 (28/41) 71.1 (27/38) 33.3 (1/3) 0.018 (< 0.20) > 0.05
PR 39.0 (16/41) 14.3 (4/24) 92.3 (12/13) 0.045 (< 0.20) > 0.05
HER2 82.9 (34/41) 62.5 (5/8) 87.9 (29/33) 0.481 (0.41-0.60) < 0.05

Values are presented as % (number/number). IHC, immunohistochemistry; OPA, overall percent agreement; PPA, positive percent agreement; NPA, negative percent agreement; RT-PCR, reverse transcription PCR; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2.

J Cancer Prev 2023;28:64~74 https://doi.org/10.15430/JCP.2023.28.2.64
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd